Banacep Vet 20 mg Film-coated Tablet for Dogs

Undetermined frequency
(cannot be estimated from the
available data):
Vomiting
Incoordination
Fatigue
Elevated creatinine*
*In dogs with chronic kidney disease, at the start of therapy. A moderate increase in
plasma creatinine concentrations following administration of ACE inhibitors is
compatible with the reduction in glomerular hypertension induced by these agents
and is therefore not necessarily a reason to stop therapy in the absence of other
signs.
In double-blind clinical trials in dogs with congestive heart failure, the veterinary medicinal
product was well tolerated with an incidence of adverse reactions lower than observed in
placebo-treated dogs.

Revised: June 2024
AN: 01837/2023
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder <or its local representative> or the national
competent authority via the national reporting system. See the package leaflet for contact
details.